Answer · read August 31, 2026
The products sold as a GLP-1 with no molecule attached, and what they cost.
4 of the 51 companies here will sell you a GLP-1 without naming the molecule in it — including the cheapest medication-included price on the whole roster, at $79 a month.
What this piece found
COMPOUNDED GLP1 + B12 · 2 mL Multiple Dose Vial · RX ONLY, and names no molecule anywhere on the page.
The census, with its denominator
51 companies published on this site. 6 carry at least one product filed as an unnamed GLP-1 — Henry Meds, Midi Health, EllieMD, Form Health, PeterMD, and Measured — which is a value this roster sets only when a company sells a GLP-1 and names no molecule for it. 4 of those publish a price for it, producing the 12 rungs in the table below; the other 2 publish no rung at all, for two different reasons given further down. Everything was read on August 31, 2026.
6 of 51, and it is a smaller number than the marketing on this market would lead you to expect — most companies here name semaglutide or tirzepatide plainly, often in the product title. The interesting part is which companies do not, and what they put in the space where the name would be.
A class, a pathway, or a brand of their own. The substitutions are consistent enough to be a house style: GLP-1 for semaglutide, GLP-1/GIP for tirzepatide, and a product name where a drug name would go.
| Company | What it is called | Term | Per month | Charged |
|---|---|---|---|---|
| Midi Health | Sublingual GLP-1, 0.075 mg | One month | $164 | $164 |
| Midi Health | Injectable GLP-1, 0.1-0.5 mg | One month | $165.90 | $165.90 |
| Midi Health | Sublingual GLP-1/GIP, 1 mg | One month | $209 | $209 |
| Midi Health | Injectable GLP-1/GIP, 1.25 mg | One month | $210 | $210 |
| Midi Health | Injectable GLP-1, 2.5 mg | One month | $355 | $355 |
| Midi Health | Injectable GLP-1/GIP, 15 mg | One month | $434 | $434 |
| Midi Health | Sublingual GLP-1/GIP, 7 mg | One month | $460 | $460 |
| EllieMD | 12-week supply, injection | 3 months | $299 | $897 |
| EllieMD | 12-week supply, oral drops, dual pathway | 3 months | $379 | $1,137 |
| PeterMD | Level 1, first-time users | 3 months | $149 | $447 |
| PeterMD | Level 2, current or returning users | 6 months | $139 | $834 |
| Measured | GLP-1 Microdose, medication included | One month | $79 | $79 |
EllieMD is the purest version. Its two injection options are GLP-1/GIP · Appetite Regulation · Dual Pathway
and GLP-1 · Satiety Support · Single Pathway, both at $299 a month for a twelve-week supply. The words describe what the drug is meant to do; nothing on the screen says what it is.
Ivy Rx goes furthest into product naming — its weight-loss page prices All treatments GLP-1 $97 ... GLP-1 Microdose $77 ... MIC + B12 Injection $179 ... Metformin $90 ... Anti-Nausea $19.99 ... GLP-1 Boost $72
, and only one of those six lines names a drug. The molecule does appear, but only once you are inside the intake: twenty-three screens in, the funnel told us you may be eligible for: Compounded Semaglutide
. The naming and the price arrive together, at the end.
Because a price with no drug attached cannot be compared to anything. The cheapest single month of compounded semaglutide on this roster is $99 and the cheapest unnamed GLP-1 is $79. Those two figures are not a comparison — one of them names the molecule and the other does not, and the difference between them could be the drug, the dose, or both.
It also decides which board a company can appear on. Every price table on this site is built per molecule, so an unnamed product sits outside all of them — whether the cheapest company is cheapest for the drug you need counts what each molecule's real field looks like, and these 4 companies are in none of the named ones.
It files the product as an unspecified GLP-1 and refuses to guess. That is a written rule in this site's roster rather than an editorial preference: a company that sells weight-loss injections without naming the drug gets recorded as selling an unnamed GLP-1, because inferring semaglutide from the phrasing would be our claim rather than theirs.
The same discipline runs through everything here. A price gets published when the company published it, an absence gets published with a census of what we read, and a molecule gets named when the seller names it. How we review sets out the rest.
They are two different findings and collapsing them would lose both. Henry Meds's fourteen-step guided intake ends on a plan screen carrying five options and no figures — Every one of the five carried a Get Started button and no price.
The amount arrives after a checkbox committing you to the full contract term, which we did not tick.
Form Health is the opposite. It sells a care program — an obesity-medicine physician, a dietitian, visits — at $299 a month, and does not sell medication at all. Its own checkout says the patient is responsible for the cost of medications not covered by insurance. There is no molecule to name because there is no drug in the price.
| Company | What we recorded | Where we read it |
|---|---|---|
| Henry Meds | Every one of the five carried a Get Started button and no price. | Henry's plan screen, 14 steps inRead 2026-08-31 |
| Form Health | The $299 a month below buys the care program | Form Health's checkout, 11 steps inRead 2026-08-31 |
It says nothing about what is in any of these products. A company that does not publish a molecule on its pricing page may name it during the intake, on the prescription, or on the vial label — several of these products carry a class and a dose, which is more than a bare name would give you. What this census records is what the public pages said on August 31, 2026.
It is also a count of records, not of products. A company appears once here whether it sells one unnamed item or seven, and the rung table below shows the difference.
Every sentence below was read on the company's own domain, or off a screen we reached ourselves, on August 31, 2026, and is quoted verbatim.
| Company | What they say, verbatim | Where we read it |
|---|---|---|
| PeterMD | COMPOUNDED GLP1 + B12 · 2 mL Multiple Dose Vial · RX ONLY | PeterMD's product pageRead 2026-08-31 |
| EllieMD | GLP-1/GIP · Appetite Regulation · Dual Pathway · Most Popular · $299/mo ($897 total) | EllieMD's selection screen, step twoRead 2026-08-31 |
| Measured | GLP-1 Microdose — Weekly lower-dose semaglutide or tirzepatide — No insurance required — Medication included — From $79/mo. | trymeasured.comRead 2026-08-31 |
| Ivy Rx | All treatments GLP-1 $97 ... GLP-1 Microdose $77 ... MIC + B12 Injection $179 ... Metformin $90 ... Anti-Nausea $19.99 ... GLP-1 Boost $72 | ivyrx.com/weight-lossRead 2026-08-31 |
| Midi Health | Midi Compounded GLP-1 ** & GLP-1/GIP: Starts at $164 per 4-week supply, depending on medication, format, and dose | joinmidi.com/weight-managementRead 2026-08-31 |
Some companies named here pay us a commission when a reader starts care through a marked link. The one marked link on this page is one of them, picked by rule and disclosed beside it. Nothing above is ordered by who pays — the rung table follows the roster's own ladder order and every figure is read out of it. Who pays us · how we review · every review.